LaBelforte launches business entities for Covid-19 nasal products development
The intranasal/inhalation products, which boost mucosal immunity, may advance the control of the disease.
India
Latest in
India
Covid-19 update: Fourth shot of vaccine can’t prevent Omicron infections
Global: The global Covid death toll has passed the grim milestone of 5.5 million, with a figure of 5,545,923 according…
DCGI grants EUA to Novavax’s Covid-19 vaccine
Serum Institute will produce and supply the recombinant nanoparticle protein-based vaccine as Covovax in India.
India grants EUA to Bharat Biotech’s Covid-19 vaccine for use in children
Covaxin showed 77.8% efficacy against mild, moderate and severe disease in Phase III trial.
Bharat Biotech seeks approval for Phase III intranasal Covid-19 vaccine trial
India’s CDSCO approved expanding the shelf life of the company’s Covaxin by up to one year from the date of…
Novavax and SII obtain WHO Emergency Use Listing for Covid-19 vaccine
Under the latest EUL, SII-manufactured vaccines are authorised to be sold as COVOVAX in India as well as licenced regions.
Middle-income countries’ healthcare sectors to keep rising through to 2024
Healthcare provision markets of middle-income countries are set to climb at an average annual rate of 5.7% in the next…
By
India seeks additional data from Serum Institute for Covovax approval
SII had sought authorisation in India for the Covid-19 vaccine for restricted use in emergencies.